Childhood-onset porphyria cutanea tarda: Successful therapy with low-dose hydroxychloroquine (Plaquenil) - 09/09/11
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
We describe a 4-year-old girl with a spontaneous blistering disorder that was consistent with porphyria cutanea tarda (PCT). There was no familial history of the disease or any obvious causative factors present. Oral hydroxychloroquine (3 mg/kg) was given twice weekly along with vitamin E (200 U/d) as an antioxidant. Within 6 weeks, marked decreased blistering occurred and by 12 weeks no blistering was evident. Despite clinical improvement and tolerance of hydroxychloroquine, urinary uroporphyrin, asparate aminotransferase, and ferritin levels continued to rise reaching peak levels at 16 weeks of therapy. Near total biochemical remission was observed at 40 weeks and all therapy was discontinued at 60 weeks. (J Am Acad Dermatol 1998;38:810-4.)
Le texte complet de cet article est disponible en PDF.Plan
 | This article is made possible through an educational grant from Ortho Dermatological. |
| Reprint requests: I. Ahmed, MD, Department of Dermatology, University of Minnesota, Box 98, 4-240 Phillips-Wangensteen Building, 420 Delaware St. SE, Minneapolis, MN 55455-0392. |
 | 0190-9622/98/$5.00 + 0 16/4/88474 |
Vol 38 - N° 5S
P. 810-814 - mai 1998 Retour au numéro
Article précédent
- Carbamazepine-induced pseudolymphoma with CD-30 positive cells
- David L. Nathan, Donald V. Belsito
- Melanoma of the soft parts (clear cell sarcoma): A case report and review of the literature
- Steven L. Mackey, Jeanette Hebel, Mark W. Cobb
Bienvenue sur EM-consulte, la référence des professionnels de santé.